Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-15-008210
Filing Date
2015-11-16
Accepted
2015-11-16 17:06:39
Documents
1
Period of Report
2015-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8076
  Complete submission text file 0000899243-15-008210.txt   9577
Mailing Address 1551 EASTLAKE AVENUE EAST, SUITE 100 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST, SUITE 100 SEATTLE WA 98102 (206) 504-7278
TAPIMMUNE INC (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: NV | Fiscal Year End: 0220
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2483 NE JULEP STREET ISSAQUAH WA 98029
Business Address
WILSON GLYNN (Reporting) CIK: 0001405625 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27239 | Film No.: 151236095